Diabetes type II
Conditions
Interventions
1. Practices in the control group:
Treatment as usual (patients will be treated by the GP as usual)
2. Practices in the intervention group:
2.1. Intervention on the practice nurse:
Participation i
Sponsors
Institute of General Practice Medicine - University of Zurich (Institut für Hausarztmedizin der Universität Zürich) (Switerland)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diabetes type II patients (Glucose in blood plasma > 7,0 mmol /l) 2. At least one measure of HbA1c > 7.0% within the last year 3. Aged older than 18 years 4. Male and female
Exclusion criteria
Exclusion criteria: 1. Insufficient German language skills 2. Patients who contacted the practice for emergencies only or as a substitute practice 3. Patients with oncological diseases and/or an estimated life expectancy of less than six months due to severe diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycated Haemoglobin (HbA1c) level, measured at baseline (T0) and 1 year (T1) | — |
Secondary
| Measure | Time frame |
|---|---|
| All measures will be assessed at baseline (T0) and 1 year (T1): 1. Guideline adherence (recommended treatment goals): Proportion of patients who achieve the recommended targets regarding: 1.1. HbA1c (=<6.5) 1.2. Blood pressure (<130/80) 1.3. Low-density lipoprotein-cholesterol (LDL-cholesterol) (<1.8 mmol/l) 2. Quality of Life, assessed by SF-36 questionnaire 3. Process quality: 3.1. Proportion of patients receiving at least one eye examination per year 3.2. Proportion of patients receiving at least one food examination per year 3.3. Proportion of patients receiving at least one nephropathy screening per year 3.4. Proportion of patients receiving at least one neurological testing per year 4. Accordance to the Chronic Care Model: 4.1. Patient Assessment of Chronic Illness Care questionnaire (PACIC-5A) 4.2. Assessment of Chronic Illness Care questionnaire (ACIC) | — |
Countries
Switzerland
Outcome results
None listed